As of 2026-03-10, the EV/EBITDA ratio of Harpoon Therapeutics Inc (HARP) is -18.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HARP's latest enterprise value is 483.51 mil USD. HARP's TTM EBITDA according to its financial statements is -26.68 mil USD. Dividing these 2 quantities gives us the above HARP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 15.9x | 15.0x |
| Forward P/E multiples | 16.3x - 21.4x | 19.0x |
| Fair Price | (19.93) - (19.46) | (20.81) |
| Upside | -186.6% - -184.6% | -190.4% |
| Date | EV/EBITDA |